February 21, 2023 12:30 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: CVS amps Mod­er­na’s CMV vac­cine tri­al; An­oth­er star in Pfiz­er’s Covid vac­ci­na­tion sky

Beth Snyder Bulik

Senior Editor

One of Mod­er­na’s clin­i­cal tri­al part­ners for its cy­tomegalovirus (CMV) vac­cine study is CVS health through its clin­i­cal tri­als busi­ness launched in 2021. And …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lex­i­con ends com­mer­cial work to fo­cus on R&D

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times